See Asa at Microbiome & Probiotic R&D & Business Collaboration Forum - La Jolla, California 10/13/2025
November 3, 2021 By: Asa Waldstein

Ingredient benefit discussions can be marketing claims

Takeaway -

Use caution when discussing ingredient benefits on a commercial webpage

Ingredient descriptions are considered marketing claims when used to sell a product.

Today’s Warning Letter Wednesday highlights this common marketing mistake. This is an example of a well-intentioned writer and webpage designer not understanding the nuances of dietary supplement marketing. If the company would have separated the ingredient benefits discussion from the product page, removed high-risk words such as infection, and noted this education is not intended to sell products, they would not have received a warning letter in my opinion.

From Warning Letter: “Copper product page: Infections: A lack of copper in the diet may lower the body’s immune system. Normal intakes may help to reduce the risk of infection.”

Read the full warning letter here.

Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading.

Written by

Asa Waldstein
Asa Waldstein
Asa Waldstein is a 24-year veteran of the dietary supplement industry, with experience spanning manufacturing, marketing, and regulatory compliance. He is the principal of Apex Compliance, a software company dedicated to streamlining regulatory marketing compliance for the dietary supplement and natural products sectors. Asa also leads Supplement Advisory Group, a boutique consultancy focused on marketing risk analysis, labeling, and practical compliance strategies for websites and social media. Asa has helped oversee three FDA GMP inspections with no 483s and was honored with the 2023 AHPA Herbal Hero Award and the 2024 What's Up Supps Policy and Change Agent Award. He currently serves as Chair of the American Herbal Products Association’s (AHPA) Cannabis Committee, helping shape policy and industry best practices